Inhibiting effect of feprazone on "in vitro" human platelet aggregation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D012459:Salicylates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D012459:Salicylates; D000244:Adenosine Diphosphate; D003094:Collagen; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin